National Agri-Marketing Association
NAMA Website
Upcoming Events
Chapters
Agri-Marketing Conf
Best of NAMA 2020












CEVA SANTE ANIMALE ACQUIRES CANADIAN RABIES MANUFACTURER ARTEMIS TECHNOLOGIES, INC.
Source: Ceva Santé Animale news release

Libourne - Ceva Santé Animale (Ceva) has acquired the Canadian oral rabies vaccine manufacturer Artemis Technologies, Inc.

Artemis, located in Guelph, ON, Canada, produces ONRAB, a rabies glycoprotein recombinant oral vaccine licensed for use in striped skunks (Mephitis mephitis) in Canada. The product also had positive field trial use in the USA in wild raccoons and skunks.

"Ceva's business purpose includes a commitment to One Health and caring for all animals. With this acquisition, we will help protect humans, wildlife, pets and livestock from the devastating effects of this lethal zoonotic disease," said Marc Prikazsky, President and CEO of Ceva Santé Animale. "We are pleased to finalize this acquisition which aligns with our goal to expand our efforts in wildlife disease management."

This strategic acquisition complements Ceva's rabies portfolio and considerable experience in rabies oral vaccine production and management of oral rabies vaccination campaigns in Europe and elsewhere. With this acquisition, Ceva will expand its presence in the segment to North America.

"Since founding Artemis in 1997, our team has worked in partnership with government authorities to help eliminate rabies in wildlife as part of their rabies management programs. We are convinced that Ceva will be able to expand on Artemis' success and continue to work with our government partners to develop innovative solutions to combat rabies in wildlife. We look forward to watching Artemis grow under Ceva's leadership," said Alex Beath, Artemis Owner, and President.

About Ceva Santé Animale
Ceva Santé Animale is a French multinational veterinary pharmaceutical company created in 1999. Chaired by Dr. Marc Prikazsky, Ceva specializes in the research, development, production and marketing of pharmaceutical products and vaccines for livestock (ruminants, swine, poultry) and companion animals. Ceva is present in 110 countries and employs over 6300 people worldwide.


Search News & Articles














Proudly associated with:
American Business Media Canadian Agri-Marketing Association National Agri-Marketing Association
Agricultural Relations Council National Association of Farm Broadcasters American Agricultural Editors' Association Livestock Publications Council
All content © 2022, Henderson Communications LLC. | User Agreement